<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40000636</article-id><article-id pub-id-type="pmc">PMC11862118</article-id>
<article-id pub-id-type="publisher-id">56833</article-id><article-id pub-id-type="doi">10.1038/s41467-025-56833-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6185-1472</contrib-id><name><surname>Grandke</surname><given-names>Friederike</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fehlmann</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8223-3750</contrib-id><name><surname>Kern</surname><given-names>Fabian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0481-9657</contrib-id><name><surname>Gate</surname><given-names>David M.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-5717-2666</contrib-id><name><surname>Wolff</surname><given-names>Tobias William</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Leventhal</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Channappa</surname><given-names>Divya</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4152-9931</contrib-id><name><surname>Hirsch</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0640-5247</contrib-id><name><surname>Wilson</surname><given-names>Edward N.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Meese</surname><given-names>Eckart</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chuanyu</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Quan</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-4374-0801</contrib-id><name><surname>Flotho</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yongping</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Cynthia</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Yeya</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jiangshan</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Junkin</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhifeng</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Longqi</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8391-4155</contrib-id><name><surname>Andreasson</surname><given-names>Katrin I.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Gansen</surname><given-names>Jenny S.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2318-2356</contrib-id><name><surname>Mass</surname><given-names>Elvira</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3424-7143</contrib-id><name><surname>Poston</surname><given-names>Kathleen</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5893-0831</contrib-id><name><surname>Wyss-Coray</surname><given-names>Tony</given-names></name><address><email>twc@stanford.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5361-0895</contrib-id><name><surname>Keller</surname><given-names>Andreas</given-names></name><address><email>andreas.keller@ccb.uni-saarland.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jdpyv68</institution-id><institution-id institution-id-type="GRID">grid.11749.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 7588</institution-id><institution>Clinical Bioinformatics, </institution><institution>Saarland University, </institution></institution-wrap>66123 Saarbr&#x000fc;cken, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jdpyv68</institution-id><institution-id institution-id-type="GRID">grid.11749.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 7588</institution-id><institution>Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)&#x02013;Helmholtz Centre for Infection Re- search (HZI), </institution><institution>Saarland University Campus, </institution></institution-wrap>Saarbr&#x000fc;cken, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Department of Neurology and Neurological Sciences, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA 94305 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05rsv9s98</institution-id><institution-id institution-id-type="GRID">grid.418356.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0478 7015</institution-id><institution>Veterans Administration Palo Alto Healthcare System, </institution></institution-wrap>Palo Alto, CA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Wu Tsai Neurosciences Institute, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Chemistry, Engineering, and Medicine for Human Health, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jdpyv68</institution-id><institution-id institution-id-type="GRID">grid.11749.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 7588</institution-id><institution>Department of Human Genetics, </institution><institution>Saarland University, </institution></institution-wrap>66421 Homburg/Saar, Germany </aff><aff id="Aff8"><label>8</label>MGI Group, San Jose, CA USA </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Program in Immunology, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/041nas322</institution-id><institution-id institution-id-type="GRID">grid.10388.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2240 3300</institution-id><institution>Life and Medical Sciences Institute, Developmental Biology of the Immune System, </institution><institution>University of Bonn, </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>The Phil and Penny Knight Initiative for Brain Resilience, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jdpyv68</institution-id><institution-id institution-id-type="GRID">grid.11749.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 7588</institution-id><institution>PharmaScienceHub, </institution><institution>Saarland University Campus, </institution></institution-wrap>Saarbr&#x000fc;cken, Germany </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1965</elocation-id><history><date date-type="received"><day>17</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The clinical course and treatment of neurodegenerative disease are complicated by immune-system interference and chronic inflammatory processes, which remain incompletely understood. Mapping immune signatures in larger human cohorts through single-cell gene expression profiling supports our understanding of observed peripheral changes in neurodegeneration. Here, we employ single-cell gene expression profiling of over 909k peripheral blood mononuclear cells (PBMCs) from 121 healthy individuals, 48 patients with mild cognitive impairment (MCI), 46 with Parkinson&#x02019;s disease (PD), 27 with Alzheimer&#x02019;s disease (AD), and 15 with both PD and MCI. The dataset is interactively accessible through a freely available website (<ext-link ext-link-type="uri" xlink:href="https://www.ccb.uni-saarland.de/adrcsc">https://www.ccb.uni-saarland.de/adrcsc</ext-link>). In this work, we identify disease-associated changes in blood cell type composition and the gene expression in a sex-specific manner, offering insights into peripheral and solid tissue signatures in AD and PD.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">Neurodegenerative diseases are linked to changes in the immune system and inflammation. Here, the authors studied immune cells from healthy individuals and neurodegenerative diseases and identified sex-specific disease-associated changes.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Biomarkers</kwd><kwd>Neural ageing</kwd><kwd>Ageing</kwd><kwd>Databases</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000864</institution-id><institution>Michael J. Fox Foundation for Parkinson&#x00026;apos;s Research (Michael J. Fox Foundation)</institution></institution-wrap></funding-source><award-id>14446, 17047 (subc. 125491594)</award-id><award-id>MJFF-021418</award-id><principal-award-recipient><name><surname>Keller</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft (German Research Foundation)</institution></institution-wrap></funding-source><award-id>466168626</award-id><principal-award-recipient><name><surname>Keller</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Neurodegenerative disorders such as Alzheimer&#x02019;s disease (AD) and Parkinson&#x02019;s disease (PD) show increasing rates of prevalence in the global population and severely affect the quality of life of the elderly<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Common risk factors include the genetic background, personal lifestyle, environmental exposure and age<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Although the clinical manifestation, diagnosis and course of progression vary substantially between AD and PD, underlying common and converging cellular pathways have been proposed<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Thereby, both diseases can arise from distinct precursor stages of varying duration and co-occur with certain shared symptoms, including (mild) cognitive decline<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. Notably, the interplay of the adaptive immune system and brain inflammation in neurodegenerative diseases is increasingly appreciated<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. In this context, substantial efforts have carved out the primary affected central nervous system (CNS) cell types and key risk genes driving the underlying pathology, e.g., <italic>APOE</italic> and <italic>TREM2</italic> in microglia for AD, or alpha-synuclein (<italic>SNCA</italic>) contained in Lewy-bodies in dopaminergic neurons for PD<sup><xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref></sup>. In a similar direction, single cell technologies facilitate to uncover the role of the human brain vasculature for the development of neurodegenerative disorders<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>.</p><p id="Par4">While the brain regions selectively affected in these diseases are subject to intense but predominantly small-scale research due to the apparent difficulties to obtain fresh-frozen human tissue samples and associated costs, research has focused on model organisms e.g., genetically modified mice, in vitro cell systems, or on the in human better accessible peripheral organic system, for example blood or cerebrospinal fluid (CSF) and their connecting interfaces such as the blood-brain barrier (BBB)<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref></sup>. Indeed, accumulating evidence points to a partial breakdown of the BBB with age and during age-related diseases, suggesting a still underestimated role of the peripheral immune system in neurodegenerative conditions, potentially through information exchange between these otherwise restrictively isolated physiological environments<sup><xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref></sup>. These findings raise questions about how and at which point during the disease progression the peripheral immune system is implicated, especially in the context of driving systemic inflammation<sup><xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref></sup>. One key factor which is increasingly considered in the pathology of AD and PD is the patients&#x02019; biological sex. Single-cell studies for AD for instance suggest that female cells are overrepresented in disease-associated subpopulations and that transcriptional responses are different between sexes in oligodendrocytes and other cell types<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Sex-dependent changes in brain and the blood of AD patients have been repeatedly reported (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). In contrast, sex-dependent changes in PD patients in the blood have so far only been reported in monocytes<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p><p id="Par5">Broadly accessible and low-invasively collectable plasma samples offer great promise for the detection of circulating biomarkers in neurodegeneration through a screening of peripheral blood mononuclear cells (PBMC), especially in large-scale settings<sup><xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref></sup>. Substantial efforts on clinical cohorts showed that plasma markers measured with analytical methods can be used to partially predict or track neurodegenerative disease development while bearing also its own challenges<sup><xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref></sup>. Thus, a next logical step is to comprehensively map molecular pathways correlating with, or even causative for these disease biomarker signatures using high-throughput techniques at high resolution. Single-cell RNA sequencing (scRNA-seq) holds the promise of unraveling cell type-specific homeostatic conditions and their alterations in human disease, as recently demonstrated for parenchymal brain tissue, brain vasculature, or PBMCs in neurodegenerative diseases<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref></sup>. Reaching numbers of up to one million cellular gene expression profiles per publication, the amount of transcriptomic data generated ranges on exponential scales and is expected to further increase<sup><xref ref-type="bibr" rid="CR45">45</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref></sup>.</p><p id="Par6">In this work, we sought to characterize the peripheral response through the transcriptional landscape<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> in neurodegeneration by profiling over 909k PBMCs of 290 blood samples including 155 samples of individuals with clinical neurodegeneration compared to 135 samples of healthy controls (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">1</xref>). We thus surpass all other currently published datasets of RNA-sequencing data of PBMCs in Alzheimer&#x02019;s and Parkinson&#x02019;s disease in both the number of patients and the number of cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>, Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). Our dataset offers insights into the general sensing of strongly CNS-associated diseases in the periphery, for the first time evaluating the potential of low-invasive cellular biomarkers for these, both at single-cell resolution and at scale. By including time-series follow-ups for a subset of the patients, as well as additional gray and white matter volume measurements and protein-levels of known AD-disease markers in the CSF, we combine a variety of patient-centric data. A companion web browser is available at <ext-link ext-link-type="uri" xlink:href="https://www.ccb.uni-saarland.de/adrcsc">https://www.ccb.uni-saarland.de/adrcsc</ext-link> and enables researchers to easily access the preprocessed dataset without requiring technical expertise and simplifies the testing of data-driven hypotheses.<fig id="Fig1"><label>Fig. 1</label><caption><title>Cohort and single-cell data characterization.</title><p><bold>a</bold> Overview on the dataset. PBMC samples were collected from healthy patients (HC), patients with Parkinson&#x02019;s Disease (PD), and patients with Cognitive Impairment (CI), more detailed with Mild Cognitive Impairment (MCI), Alzheimer&#x02019;s Disease (AD), and Parkinson&#x02019;s Disease with Mild Cognitive Impairment (PD-MCI). For a subset of patients, blood samples were drawn at multiple time-points. The samples were then profiled using single-cell RNA sequencing. For a subset of patients, additional data was collected on brain volumes (158 patients) and known Alzheimer biomarkers were measured in the CSF (40 patients). <bold>b</bold> Distribution of biological sex and age per patient group (divided by sex). The violin plots show the shape of the distribution, while the boxes encompass the first through third quartiles, with the central line marking the median. The whiskers mark the minimum or maximum values or, if outliers are present, the values within 1.5 times the interquartile range of the first or third quartile. Outliers are shown as dots. <bold>c</bold> Two-dimensional representation of the <italic>n</italic>&#x02009;=&#x02009;909k cells using Uniform Manifold Approximation and Projection (UMAP). Cells are colored by assigned cell type. <bold>d</bold> Cells are annotated on different levels. This allows the analysis on a broad level with 13 bigger clusters or on a finer level with 33 clusters.</p></caption><graphic xlink:href="41467_2025_56833_Fig1_HTML" id="d33e626"/></fig></p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>A scRNA-seq dataset of PBMCs in neurodegenerative diseases</title><p id="Par7">From the Stanford Alzheimer&#x02019;s Disease Research Center (ADRC) we selected patients diagnosed with mild cognitive impairment (individual patients n&#x02009;=&#x02009;48, total samples from the patients n<sub>t</sub>&#x02009;=&#x02009;55; MCI), Alzheimer&#x02019;s disease (n&#x02009;=&#x02009;27, n<sub>t</sub>&#x02009;=&#x02009;34; AD), Parkinson&#x02019;s disease (n&#x02009;=&#x02009;46, n<sub>t</sub>&#x02009;=&#x02009;48; PD), PD with MCI (<italic>n</italic>&#x02009;=&#x02009;15, n<sub>t</sub>&#x02009;=&#x02009;18; PD-MCI), and healthy individuals (<italic>n</italic>&#x02009;=&#x02009;121, n<sub>t</sub>&#x02009;=&#x02009;135; HC) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). We ensured a well-balanced ratio of both biological sex and age between the subgroups (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref>). For each sample, we performed droplet-based single-cell RNA-sequencing<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> on collected PBMCs, totaling 1,374,714 cellular expression profiles. We then kept the top 909,322 single cells of highest quality (66%) that passed stringent quality control filtering (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2b</xref>). Following a cluster-based cell type annotation and manual marker curation, we found 13 major PBMC types that were further divided into 33 fine-granular sub-cell types (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>). The downstream analysis described in this paper was performed using only the baseline sample of each patient (unless stated otherwise).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic breakdown of the patients included in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="3">Age in females (mean, sd and number of patients)</th><th colspan="3">Age in males (mean, sd and number of patients)</th><th colspan="3">Adj. P-value (m vs. f)</th></tr></thead><tbody><tr><td rowspan="5">Diagnosis</td><td>HC</td><td colspan="3">72&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;82)</td><td colspan="3">75&#x02009;&#x000b1;&#x02009;9 (n&#x02009;=&#x02009;53)</td><td colspan="3">0.318</td></tr><tr><td>AD</td><td colspan="3">71&#x02009;&#x000b1;&#x02009;10 (n&#x02009;=&#x02009;21)</td><td colspan="3">73&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;13)</td><td colspan="3">1</td></tr><tr><td>PD</td><td colspan="3">69&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;23)</td><td colspan="3">69&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;25)</td><td colspan="3">1</td></tr><tr><td>MCI</td><td colspan="3">73&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;29)</td><td colspan="3">76&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;26)</td><td colspan="3">1</td></tr><tr><td>PD-MCI</td><td colspan="3">68&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;6)</td><td colspan="3">73&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;12)</td><td colspan="3">1</td></tr><tr><td rowspan="3">Race</td><td>White (w)</td><td colspan="3">71&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;144)</td><td colspan="3">74&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;116)</td><td colspan="3">0.101</td></tr><tr><td>Asian (a)</td><td colspan="3">72&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;12)</td><td colspan="3">72&#x02009;&#x000b1;&#x02009;14 (n&#x02009;=&#x02009;9)</td><td colspan="3">1</td></tr><tr><td>Other (o)</td><td colspan="3">73&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;5)</td><td colspan="3">74&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;4)</td><td colspan="3">1</td></tr><tr><td/><td>Race</td><td>w</td><td>a</td><td>o</td><td>w</td><td>a</td><td>o</td><td>w</td><td>a</td><td>o</td></tr><tr><td rowspan="5">Diagnosis</td><td>HC</td><td>72&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;72)</td><td>71&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;6)</td><td>71&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;4)</td><td>76&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;49)</td><td>64&#x02009;&#x000b1;&#x02009;20 (n&#x02009;=&#x02009;4)</td><td>- (n&#x02009;=&#x02009;0)</td><td>0.148</td><td>1</td><td>-</td></tr><tr><td>AD</td><td>70&#x02009;&#x000b1;&#x02009;10 (n&#x02009;=&#x02009;18)</td><td>75&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;3)</td><td>- (n&#x02009;=&#x02009;0)</td><td>73&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;13)</td><td>- (n&#x02009;=&#x02009;0)</td><td>- (n&#x02009;=&#x02009;0)</td><td>1</td><td>-</td><td>-</td></tr><tr><td>PD</td><td>69&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;22)</td><td>67 - (n&#x02009;=&#x02009;1)</td><td>- (n&#x02009;=&#x02009;0)</td><td>68&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;23)</td><td>73&#x02009;&#x000b1;&#x02009;4 (n&#x02009;=&#x02009;2)</td><td>- (n&#x02009;=&#x02009;0)</td><td>1</td><td>-</td><td>-</td></tr><tr><td>MCI</td><td>73&#x02009;&#x000b1;&#x02009;8 (n&#x02009;=&#x02009;26)</td><td>69&#x02009;&#x000b1;&#x02009;11 (n&#x02009;=&#x02009;2)</td><td>83 - (n&#x02009;=&#x02009;1)</td><td>75&#x02009;&#x000b1;&#x02009;6 (n&#x02009;=&#x02009;20)</td><td>83&#x02009;&#x000b1;&#x02009;1 (n&#x02009;=&#x02009;2)</td><td>74&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;4)</td><td>1</td><td>-</td><td>-</td></tr><tr><td>PD-MCI</td><td>68&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;6)</td><td>- (n&#x02009;=&#x02009;0)</td><td>- (n&#x02009;=&#x02009;0)</td><td>72&#x02009;&#x000b1;&#x02009;7 (n&#x02009;=&#x02009;11)</td><td>78 - (n&#x02009;=&#x02009;1)</td><td>- (n&#x02009;=&#x02009;0)</td><td>1</td><td>-</td><td>-</td></tr></tbody></table><table-wrap-foot><p>More detailed information can be found in Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">1</xref>.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Sex-specific changes in cell type proportions</title><p id="Par8">As visualizing those large cell numbers in a 2-dimensional embedding becomes unclear - a phenomenon commonly denoted as overplotting - we estimated the density of cells to highlight the distribution of cells for each diagnosis group (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4a</xref>). Interpreting the projected densities, we found slight differences in the distribution of cells, suggesting a disease-specific transcriptomics shift in the overall abundance of different cell type populations. In light of previous reports indicating that changes in cell type proportions in PBMC samples may differ between males and females<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, we separated the data by sex to independently examine disease-related changes. In general, we observed distinct changes in the cell type proportions in men and women (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4b</xref>). A density analysis depicts these effects in the integrated data space (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Sex-dependent changes of cell type proportions.</title><p><bold>a</bold> Differential density UMAP embedding for male and female patients shows differences in the cell type distribution for AD, PD and MCI. Each embedding shows the spots with the highest density of the diseased patient group (red) or the healthy control group (blue). <bold>b</bold> Comparison of the cell type proportions (on the broad annotation) using scCODA with Age and ApoE as covariates. Celltypes with an absolute Fold-change of at least 0.5 that were reported as significant by scCODA are marked with a dot. <bold>c</bold> Relative change in the cell type-proportion in % between Healthy and the diagnosis groups for the different cell types reveals sex-specific changes. Significant values (adj. p-value&#x02009;&#x0003c;&#x02009;0.05, unpaired Student&#x02019;s t-test) are marked by a frame, previously described changes from the literature are marked with a dot. <bold>d</bold> Comparison of the changes of cell type proportions found in the literature and the cell type proportion changes found in our PBMC data using scCODA. Changes are only considered if they were reported as significant by scCODA between healthy and disease. If no sex is given, the test was performed without considering the sex. <bold>e</bold> Comparison of the cell type proportions on the fine Annotation using scCODA as described in (<bold>b</bold>). Celltypes with an absolute Fold-change of at least 1 that were reported as significant by scCODA are marked with a dot.</p></caption><graphic xlink:href="41467_2025_56833_Fig2_HTML" id="d33e956"/></fig></p><p id="Par9">These sex-dependent changes were confirmed using scCODA, which did not show significant changes in the cell-type distributions (abs log2FC&#x02009;&#x0003e;&#x02009;0.35, significant according to scCODA) when leaving out sex as a covariate (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4c</xref>). Split by male and female patients, we were able to observe significant changes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>), some of which were different dependent on the sex. In Parkinson&#x02019;s disease, CD8&#x02009;+&#x02009;T cells and Plasma cells show a positive fold-change in males but a negative fold-change in females. Similarly, B cells are more abundant in females with PD-MCI but less abundant in males with PD-MCI. Although a sex-dependent change in B and NK cells of AD patients was indicated in the density embedding, scCODA did not show a significant difference. In the finer cell-annotation, we observed significant changes in only 3 cases in males and 9 cases in females using the raw cell type proportions (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). The significant changes in AD, MCI and PD match the ones found in the female patients (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4d</xref>). Using scCODA on the finer Annotation, we found a lower proportion of T<sub>fh</sub> cells in AD, as previously reported (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>). When comparing these findings with previously reported changes, some were previously described by others, such as the increased proportion of Monocytes in AD, and changes in B cells in PD (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e</xref>).</p><p id="Par10">Several but not all of the changes we report in this study have been previously described by others, such as the increased proportion of B cells in AD, and changes in CD8&#x02009;+&#x02009;T cells in PD. Overall, our results suggest a significant shift in the cellular composition of male and female patients, with disease-specific differences. An important question to consider is whether these changes are driven by small, distinct sets of genes, or broader transcriptomic perturbations.</p></sec><sec id="Sec5"><title>Differences in the sex-specific transcriptome</title><p id="Par11">To gain further insight into the respective molecular changes among male and female patients with MCI, AD, or PD, we conducted a DEG analysis (Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">2</xref>). As the sample sizes of PD-MCI is too small for most analysis we excluded it from further in-depth consideration. Our analysis aims to identify both, sex- and disease-related differences in gene expression. We revealed a stark contrast between sexes in the number of DEGs, particularly in Alzheimer&#x02019;s patients, which has been previously noted by Mathys et al. <sup><xref ref-type="bibr" rid="CR11">11</xref></sup> (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>). Specifically, we detected de-regulated genes in only 12 cell types in male patients, whereas in female patients 20 cell types exhibited de-regulated genes. A similar, albeit less sex-pronounced trend was observed in the comparison between PD and HC, as well as MCI vs. HC patients. We then compared the fold-changes in male and female subgroups and found a positive correlation for MCI vs. HC (overall correlation of 0.35, p-value&#x02009;&#x0003c;&#x02009;2.2 &#x02217; 10<sup>&#x02212;&#x02009;16</sup>) and AD vs. HC (overall correlation of 0.32, p-value&#x02009;&#x0003c;&#x02009;2.2 &#x02217; 10<sup>&#x02212;&#x02009;16</sup>), particularly in cell types with a high number of significantly de-regulated genes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Conversely, cell types in PD vs. HC exhibited lower or no correlation at all that are often negative (overall correlation = &#x02212;0.0064, p-value&#x02009;=&#x02009;0.098). Overall, our analysis revealed that most of the cell types in the PD vs. HC comparison were either negatively (9 cell types) correlated or not significantly correlated while most cell types exhibited a positive correlation in both AD (22 cell types) and MCI (22 cell types) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>). In total, we identified only 84 genes that were de-regulated independent of the sex. Most of these genes were found in CD4+ T<sub>cm</sub>/T<sub>scm</sub> T cells, NKT-like cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>) or in CD56-Dim, CD16 NK cell. These findings lead us to evaluate if the similarities between the different diseases varies by sex. We thus determined the overlap between the significantly de-regulated genes in the three diseases to control comparisons. The distribution of shared genes between diseases in males (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e</xref>) compared to those in females (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f</xref>) is similar and significantly de-regulated genes are mainly shared between MCI vs. HC and PD vs. HC. In particular, 35 genes are differentially expressed in all three comparisons for male and 27 for female patients. Overall, our results thus suggest rather sex-independent expression patterns in the different diseases, while in certain cases - depending on the disease and cell type - the signatures for the sexes differ substantially. When comparing the gene-expression changes in the different cell-types, we observed that the changes&#x000a0;in sub-cell types from the same cell type show a high similarity (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Changes in gene-expression patterns in male and female patients.</title><p><bold>a</bold> Comparison of the number of genes that are significantly de-regulated (adj. p-value&#x02009;&#x0003c;&#x02009;0.05 and absolute log2 fold-change &#x0003e; 0.5, see Methods) between the healthy and diseased patients in females and in males. <bold>b</bold> Cell types with more significantly de-regulated genes (as in a) show higher correlation values in AD and MCI. The Pearson correlation coefficient was calculated between the fold-changes in male and female of all genes in the dataset. <bold>c</bold> Correlations of the fold-changes in male and female patients in PD is often lower and in 9 cell types negative, but positive in most cell types in MCI and AD. Significant values (Pearson&#x02019;s correlation, adj. p-value&#x02009;&#x0003c;&#x02009;0.05) are marked with a dot. <bold>d</bold> Comparison of the log2 Fold-changes in male and female patients in CD4+ T<sub>cm</sub>/T<sub>scm</sub> cells and NKT-like cells shows the number of genes that are significantly de-regulated in both or only one sex. The genes are colored by the sex in which they are significant in (adj. p-value&#x02009;&#x0003c;&#x02009;0.05, see Methods). <bold>e, f</bold> Upset plot showing the number of significantly de-regulated genes that are shared between the different comparisons of healthy with the diagnosis groups for the male sub-group (e) and for the female sub-group (f) show similar patterns in the overlap between diseases in both sexes.</p></caption><graphic xlink:href="41467_2025_56833_Fig3_HTML" id="d33e1051"/></fig></p></sec><sec id="Sec6"><title>Peripheral pathways affected in neurodegeneration</title><p id="Par12">In the light of the significant variability in gene expression patterns among diseases, cell types, and sexes, we sought to verify that signatures in our dataset reflect the dysregulation of known disease gene markers. To accomplish this, we specifically analyzed genes from the KEGG Alzheimer&#x02019;s disease and Parkinson&#x02019;s disease pathways that were de-regulated in our PBMCs. Astonishingly, we found that gene expression in the KEGG Alzheimer&#x02019;s disease pathway is largely independent of both sex and cell type. This might be due to a bias in how the genes on the pathways are identified in previous studies, largely excluding sex specific effects. While the fold-changes in some cell types differ between sexes, the direction of the de-regulation is consistent (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6a</xref>). Conversely, we observed differences in gene expression between males and females and between different cell types for some genes in the KEGG Parkinson&#x02019;s disease pathway (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6b</xref>).</p><p id="Par13">This poses the question, which pathways are affected specifically in males and females. The results of a pathway analysis of the change in all cell-types and sexes (Supplementary Data&#x000a0;<xref rid="MOESM5" ref-type="media">3</xref>) shows that the affected pathways in AD and in MCI are similar in both sexes (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>). In PD the pathways are more sex specific. The overall most frequently enriched pathway in AD is &#x0201c;SRP-dependent cotranslational protein targeting to membrane&#x0201d;. This is also the most frequently enriched pathway in females MCI and males with PD (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). In PD, the &#x0201c;Asthma&#x0201d; pathway is most affected in females and in MCI &#x0201c;Oxidative phosphorylation&#x0201d; in males.<fig id="Fig4"><label>Fig. 4</label><caption><title>Pathways analysis shows sex-dependent changes in PD and MCI.</title><p><bold>a</bold> The number of cell types in which a pathway is enriched or depleted in males and females in the different comparisons. The dots are colored if they occur only in males or in females. <bold>b</bold> Number of occurrences of the top 5 most frequently enriched and depleted pathways in each comparison and sex. <bold>c, d</bold> Size of the overlap of the pathways in the different comparisons, independent of cell type for males (<bold>c</bold>) and females (<bold>d</bold>).</p></caption><graphic xlink:href="41467_2025_56833_Fig4_HTML" id="d33e1095"/></fig></p><p id="Par14">In PD, MCI and in males in AD, the pathways are similar across all cell-types (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>). In females with AD, B cells show a similar cluster of pathways consisting of pathways related to junctions (adherens junction, cell-substrate junction, cell-substrate adherens junction) and pathways related to catabolic and biosynthetic processes (&#x0201c;amide biosynthetic process&#x0201d;, &#x0201c;aromatic compound catabolic process&#x0201d;,&#x02026;). In males, these pathways appear across all groups of cell-types.</p><p id="Par15">Overall, there are 15 pathways shared between PD, MCI and AD in females, but 53 in males (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c, d</xref>). 114 pathways are shared between AD and PD in males and 24 in females.</p></sec><sec id="Sec7"><title>Similar disease signatures in PBMCs and neural cells</title><p id="Par16">Having determined changes that can be observed between Alzheimer&#x02019;s disease and healthy controls in PBMC samples, we sought to contrast peripheral cell transcriptomes to those from the brain. A large number of studies describe single cell gene expression across multiple regions in the brain with respect to different disease phenotypes and physiological conditions, complicating a joint analysis.</p><p id="Par17">We thus used a database that integrates single cell gene expression data from 21 studies, allowing for precise insights into the regulation of genes across cell types in relation to age, sex, and disease (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref>)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. As there are not enough cells from the same cell-type in both brain and blood, we rely on overlaps of gene-expression patterns and pathways when looking for similar patterns in neurodegenerative diseases.<fig id="Fig5"><label>Fig. 5</label><caption><title>Comparison of gene-expression in brain and blood of Alzheimer&#x02019;s patients.</title><p><bold>a</bold> Single-cell RNA-sequencing data from the cortex from the ZEBRA-dataset was used for the comparison of changes in PBMC samples and brain samples. <bold>b</bold> Fold-changes in PBMCs and cortex of the genes with an adj. p-value&#x02009;&#x0003c;&#x02009;0.05 (see Methods) in the PBMCs the brain in males. <bold>c</bold> De-regulation of genes in PBMCs and cortex with an adj. p-value&#x02009;&#x0003c;&#x02009;0.05 in PBMCs and the brain and an abs. log2 fold-change bigger than 0.6 in the PBMCs (see Methods). <bold>d, e</bold> Deregulation of the significantly de-regulated genes in all three datasets (see Methods) and the direction of de-regulation in males (<bold>d</bold>) and females (<bold>e</bold>) (&#x02009;+&#x02009;: Up-regulated in all cell-types, -: Down-regulated in all cell-types and *: Mixed signals). Genes are annotated with the context in which they have been previously reported in for Alzheimer&#x02019;s (see Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>). <bold>f</bold> Top 10 most frequently enriched or depleted pathways in both brain datasets and in PBMCs and the proportion of cell-types they are enriched/depleted in.</p></caption><graphic xlink:href="41467_2025_56833_Fig5_HTML" id="d33e1151"/></fig></p><p id="Par18">We identified genes that exhibit differential expression patterns between Alzheimer&#x02019;s disease and healthy individuals in male and female patients for the PBMCs and investigated whether these exhibit similar expression patterns in brain cells of Alzheimer&#x02019;s patients (Supplementary Data&#x000a0;<xref rid="MOESM6" ref-type="media">4</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8a</xref>). Our findings suggest that gene expression changes in peripheral cells may not necessarily reflect those in the brain, given the natural disparity of cell types between blood and brain. However, emphasizing the need for further in-depth investigation knowing the role of the immune system in Alzheimer&#x02019;s, the associated brain inflammation and infiltration by specifically activated immune cells.</p><p id="Par19">Overall, there were 36 genes in males and 7 genes in females that were significantly de-regulated in both PBMCs and the brain in the main cell-types (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b, c</xref>). The genes in males (adj. P-value&#x02009;&#x0003c;&#x02009;0.05 and abs. log2 Fold-change &#x0003e; 0.5 in both datasets) were enriched for pathways related to the regulation of the immune system and the membrane (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8b, c</xref>). The female genes (adj. P-value&#x02009;&#x0003c;&#x02009;0.05 in both datasets) were enriched for the Herpes Simplex Virus 1 pathway. Herpes simplex has previously been linked to an increased risk for the development of Alzheimer&#x02019;s and is discussed as a key factor in disease development<sup><xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>.</p><p id="Par20">To further validate these findings and to see if the expression changes with different brain-regions, we tested for the general overlap of differentially expressed genes (abs. log2 Fold-change &#x0003e; 0.5 and adj. P-value&#x02009;&#x0003c;&#x02009;0.05) in this PBMC dataset, the ZEBRA dataset (21 studies) and an additional ROSMAP dataset (4 studies; 6 brain regions) (Supplementary Data&#x000a0;<xref rid="MOESM7" ref-type="media">5</xref>). Of note, two studies from the prefrontal cortex samples of the ROSMAP dataset are a subset of the ZEBRA dataset and thus not independent. The other brain-regions are independent between the datasets. We found an overlap of 32 genes in the male patients and 8 genes in the female patients. 24 out of the 32 male genes and 5 out of the 8 female genes have been previously reported in the context of Alzheimer&#x02019;s disease, most in the context of the immune system, blood-brain barrier, Astrocytes and Microglia (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>, Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d, e</xref>).</p><p id="Par21">To gain a deeper understanding for the changes in PBMCs and brain cells and how they might interact, we compared the de-regulated genes with the CellChat signaling database<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. We found genes from the <italic>CCL</italic> (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8d</xref>) and the <italic>MHC-I</italic> signaling pathway in the de-regulated genes in females and the <italic>CD45</italic> and the <italic>CCL</italic> signaling pathway in males. All of these genes have already been reported in the context of Alzheimer&#x02019;s in the literature<sup><xref ref-type="bibr" rid="CR55">55</xref>&#x02013;<xref ref-type="bibr" rid="CR57">57</xref></sup>. This indicates that changes in the blood might influence the brain or vice versa, but as there are only few genes of these pathways de-regulated, further experiments would be necessary to confirm this.</p><p id="Par22">Additionally, we performed a pathway analysis using both the de-regulated genes in male and female samples (Supplementary Data&#x000a0;<xref rid="MOESM8" ref-type="media">6</xref> and <xref rid="MOESM9" ref-type="media">7</xref>). We observed a general enrichment of membrane, ribosome, and adherens junction-related pathways in both blood and brain (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5f</xref>). Especially the &#x0201c;SRP-dependent cotranslational protein targeting to membrane&#x0201d; pathway is frequently enriched in all three datasets. This suggests that the observed symptoms might be caused by a systemic change that affects both blood and the brain.</p><p id="Par23">To further investigate the relationship between changes in the gene-expression in both tissues, we compared them to an additional bulk RNA-sequencing dataset from the ROSMAP cohort (Synapse <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn3388564">https://www.synapse.org/#!Synapse:syn3388564</ext-link>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8e</xref>). Although fold-changes in the brain single-cell and bulk data showed a significant positive correlation (overall correlation: 0.14, p-value: 0.00025), we did not find a significant correlation of the PBMC single-cell with the brain bulk data (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8f</xref>).</p></sec><sec id="Sec8"><title>Access for the community</title><p id="Par24">To allow easy, fast and uncomplicated data access to our large-scale findings, we developed a webserver for the dataset. The web-resource allows the visualization of gene-expression values (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">9a, b</xref>). The direct access to the list of de-regulated genes and its visualization (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">9c</xref>) allow fast hypothesis-testing.</p><p id="Par25">In addition to the scRNA-seq data used for the analysis shown in this manuscript, the webserver also allows researchers to access the longitudinal data, brain volume measurements and CSF-marker values.</p><p id="Par26">Our dataset contains 32 patients with more than 1 time-point (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10a</xref>) and 3 with more than 2. All patient with 3 Visits were female and we observed differences in the age-distribution between male and female patients in this subgroup (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10b</xref>). The average time between the first and second visit was less than a year for AD and between 2 and 3 years for the other diseases (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10c</xref>). When correlating the cell-type proportions with the number of the visit, we observed no significant correlations (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10d</xref>). Generally, both the cell-type proportions of the same patient at different visits and between different patients show large fluctuations (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10e</xref>).</p><p id="Par27">Although the statistical power of the longitudinal data is limited, we included it on the website, allowing interested researchers to study this data in more detail. We additionally included the data of the brain volume measurements (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11a</xref>) and CSF-marker values (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11b</xref>) for direct comparison. Similarly to the time-series data, we correlated it with the cell-type proportions (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11c</xref>). We found significant correlations (adj. P-value&#x02009;&#x0003c;&#x02009;0.05) mainly in healthy controls. We still include this data as a resource for other researchers.</p><p id="Par28">Our dataset showed sex-dependent differences in the changes of the cell type composition and in the gene-expression profiles of neurodegenerative diseases and Parkinson&#x02019;s disease specifically.</p></sec></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p id="Par29">The era of single-cell -omics has enabled studying human diseases at an unprecedented cellular resolution combined with massive throughput, generating millions of transcriptomic profiles at ease. While large-scale single-cell analysis of fresh-frozen post-mortem brains seems to come in close reach for the upcoming years, it is of great importance to understand which systemic changes precede and co-occur neurodegeneration in the human body as to inform our current understanding of early biomarkers as well as individualized risk or progression markers. Our dataset is composed of 290 gene-expression profiles of PBMCs from MCI, AD, PD, PD-MCI and HC individuals and includes additional information about Brain volume measurements and CSF-biomarker levels of known AD biomarkers. This dataset allows us to generally study disease- and sex-specific changes in patients with neuro-degenerative diseases.</p><p id="Par30">To study the exact mechanisms, a more specialized dataset with more samples (e.g. for AD)<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and additional demographic and clinical information (e.g. medication use, other disease, lifestyle factors,&#x02026;) would be necessary. Changes in the sub-cell types and potential sub-groups in the cell clusters furthermore need to be studied in more targeted experiments, as the number of cells in each of these clusters is limited.</p><p id="Par31">When comparing the cell type composition, we found large differences between the changes in men and women that are often specific for certain sub-cell types. Changes in B cells and Monocytes in Alzheimer&#x02019;s disease were inconsistent across male and female patients. It has been previously shown that depletion of B cells from mice led to cognitive deficits and an increase of A&#x003b2; plaques<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. B cells also play an important role in the regulation of local immune responses and might thus indicate inflammatory states in Alzheimer&#x02019;s. The increased levels of monocytes in AD can furthermore be a sign of chronic inflammation and may have a negative effect on structures like the blood brain barrier (BBB)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. In contrast to the large sex-specific differences in the PD cell type compositions that we observed, previous studies mainly found changes in the T-cell population of Parkinson&#x02019;s patients. Of note, the findings of the previous studies sometimes contradict each other. This can be partially explained by the large fluctuations in the cell type composition that can be observed even of the same patient<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> so that differences in the cell type composition can vary largely between samples. Moreover, some of our findings have not yet been documented, or only partially align with previous studies. This could be attributed to biases in the cohorts used (such as differences in ethnicity, disease severity, or other factors), technological limitations, or other biases.</p><p id="Par32">To identify sex- and disease-specific gene signatures, a machine-learning model was applied to the dataset (<xref rid="MOESM1" ref-type="media">Supplementary Notes</xref>&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>, Supplementary Data&#x000a0;<xref rid="MOESM10" ref-type="media">8</xref>). Testing out a random forest-based feature selection and three other machine-learning methods, we concluded that the application on an Alzheimer&#x02019;s disease dataset is too complex and would require a larger dataset (ideally with different studies) to reliably predict disease-specific features across patients.</p><p id="Par33">The data furthermore suggest sex-specific differences between gene-expression signatures of PD, more similarities, but still sex-specific differences in AD. Sex-specific differences in PD have been previously found in Monocytes<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> but sex-independent expression-changes were reported in T-Memory cells<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. We have found an anti-correlation of gene-expression changes in male and female indicating large differences between the disease-specific changes in PD, while the sex-specific differences in AD can be mainly observed by the effect size of the gene-expression change. We have seen that we found much more DEGs in female patients than in male patients. Even though this effect can be observed across all diseases in this study, it is particularly strong in AD, which has previously been reported by Mathys et al. <sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In Parkinson this effect has been described previously in blood Monocytes<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, whereas the exact opposite case has been observed in the brain<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.</p><p id="Par34">The changes that were observed in Alzheimer&#x02019;s disease independent of the sex mainly focused on genes from the &#x0201c;SRP-dependent cotranslational protein targeting to membrane&#x0201d; pathway. This pathway has been previously reported in Alzheimer&#x02019;s disease<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> and Parkinson&#x02019;s disease<sup><xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. This indicates similar changes in male and female Alzheimer&#x02019;s patients and male Parkinson&#x02019;s patients. Changes in those genes have been showing an increased expression during microglia activation, a state that has previously been associated with Alzheimer&#x02019;s<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>.</p><p id="Par35">The &#x0201c;SRP-dependent cotranslational protein targeting to membrane&#x0201d; pathway has also been observed in brain samples from both the ZEBRA and the ROSMAP dataset. The genes involved thus do not only show changes in PBMC, but also the Brain. The genes of this pathway have previously been discussed in the context of periodontitis, a condition mainly caused by <italic>Porphyromonas gingivali</italic><sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. This bacterium is known to secrete gingipains, which have been linked to Alzheimer&#x02019;s pathology in mice and humans<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>.</p><p id="Par36">Diving deeper into the changes that are observed in both the blood and the brain, we found 30 overlapping genes in males and 7 in females that are significantly deregulated in both blood and the brain. A majority of those genes have been previously reported in relation to Alzheimer&#x02019;s disease in different tissues and cell-types (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>). These include genes related to changes in the Immune system and the Blood-brain barrier (especially in females) and changes related to Astrocytes and Microglia. This indicates general changes in the immune system, possibly in relation to an infection (such as herpes simplex) or age-related inflammation processes. The infection with Herpes simplex can lead to a higher risk of developing Alzheimer&#x02019;s in APOE4 carriers<sup><xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup> and is discussed to play a major role in the disease development.</p><p id="Par37">As patients of the ADRC cohort are continuously monitored, two major shortcomings of our study will be addressed in the future. First, longitudinal trajectories will be important to trace down the temporal dynamics on the molecular level. Second, a patient-matched analysis of both brain and blood tissue will enable us to validate the here reported effects ruling out inter-individual variation.</p><p id="Par38">In sum, our dataset indicates that there are strong sex-related differences in the neuro-degenerative diseases discussed in this study. While the exact relationship between the immune-system and the brain remains unknown, this study highlights the importance to consider possible influences of the immune system and the sex on the development of these diseases. Beyond the analyses that we provide in the present study, we are convinced that exploring the very broad dataset supports a broad range of further research topics. We thus make not only the raw data available but also implemented a convenient web interface with substantial functionality to explore the data (<ext-link ext-link-type="uri" xlink:href="https://www.ccb.uni-saarland.de/adrcsc">https://www.ccb.uni-saarland.de/adrcsc</ext-link>).</p></sec><sec id="Sec10"><title>Methods</title><sec id="Sec11"><title>Cohort</title><p id="Par39">The patients included in the study were enrolled by the Stanford Alzheimer&#x02019;s Disease research Center (ADRC). The group of patients includes patients diagnosed with mild cognitive impairment (individual patients n&#x02009;=&#x02009;51, total samples from the patients n<sub>t</sub>=63; MCI), Alzheimer&#x02019;s disease (n&#x02009;=&#x02009;31, n<sub>t</sub>=43; AD), Parkinson&#x02019;s disease (n&#x02009;=&#x02009;55, n<sub>t</sub>=61; PD), PD with MCI (n&#x02009;=&#x02009;20, n<sub>t</sub>=24, PD-MCI), and healthy individuals (n&#x02009;=&#x02009;154, n<sub>t</sub>=172, HC). We selected patients with respect to a similar ratio of both biological sex and age between the subgroups. The Stanford University IRB approved the study and all patients provided written informed consent. Due to the strict quality control, the final dataset only contains a total of 290 samples from 257 individuals. CSF measurements were performed for NFL, UCHL1, Tau and GFAP&#x000a0;(Quanterix4plex), Ab40, Ab42 and Tau (Quanterix3plex) and pTau181 (Quanterix). Brain Volume measurements were performed using PET and MRI imaging.</p></sec><sec id="Sec12"><title>Single-cell suspension preparation</title><p id="Par40">Frozen PBMCs vials were rapidly thawed in a 37&#x02009;&#x000b0;C water bath for 2&#x02009;minutes, and the vials were removed when a tiny ice crystal was left. Thawed PBMCs were quenched with 13&#x02009;ml 37&#x02009;&#x000b0;C pre-warmed 1X phosphate-buffered saline (PBS, Thermo Fisher Scientific, #10010031) supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, #A3160601). Cells were centrifuged at 300 x g for 10&#x02009;minutes at room temperature. The supernatant was removed, and cell pellet was resuspended in 3&#x02009;ml 1X PBS containing 10% FBS, passed through a 40&#x02009;&#x000b5;m cell strainer (Falcon, #352340), then centrifuged at 300 x g for 10&#x02009;minutes at room temperature. Dead cells were removed by magnetic beads purification (Miltenyi Biotech, #130-090-101) according to the manufacturer&#x02019;s protocol. Cells were resuspended with cell resuspension buffer at a concentration of 1000 viable cells/&#x000b5;l.</p></sec><sec id="Sec13"><title>Single-cell RNA-seq with DNBelab C4 system</title><p id="Par41">The DNBelab C Series Single-Cell Library Prep Set (MGI, #1000021082) was utilized as previously described<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. In brief, single-cell suspensions were used for droplet generation, emulsion breakage, beads collection, reverse transcription, and cDNA amplification to generate barcoded libraries. Indexed scRNA-seq libraries were constructed according to the manufacturer&#x02019;s protocol. The DNA nanoballs (DNBs)-based libraries were sequenced by the ultra-high-throughput DIPSEQ T1 sequencer at China National GeneBank (CNGB). The read structure was paired-end with Read 1, covering 30 bases inclusive of 10-bp cell barcode 1, 10-bp cell barcode 2 and 10-bp unique molecular identifier (UMI), and Read 2 containing 100 bases of transcript sequence, 10-bp sample index.</p></sec><sec id="Sec14"><title>Primary single-cell RNA-seq data processing</title><p id="Par42">Raw sequencing reads from DIPSEQ T1 sequencer were filtered and demultiplexed using PISA (version 0.2) (<ext-link ext-link-type="uri" xlink:href="https://github.com/shiquan/PISA">https://github.com/shiquan/PISA</ext-link>). Reads were aligned to hg38 genome using STAR<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> (version 2.7.4a), and sorted by sambamba<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> (version 0.7.0). Genes were annotated according to GENCODE<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Cell versus gene UMI count matrix was generated with PISA.</p></sec><sec id="Sec15"><title>Quality control and data processing</title><p id="Par43">For each count matrix, SoupX<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> (1.4.8) was used to estimate and remove ambient RNA contamination. Only samples with at most 10% estimated contamination were kept for further analyses. Subsequently samples were filtered such that each sample contained at least 300 cells, each cell contained at most 7% mitochondrial gene counts and between 300 and 4000 genes were expressed per cell. Doublet filtering was also performed sample-wise using the R Bioconductor package scDblFinder<sup><xref ref-type="bibr" rid="CR73">73</xref></sup> 1.2 with an expected doublet ratio of 1% per 1000 cells. Next, all samples were merged.</p></sec><sec id="Sec16"><title>Dimensionality-reduction and clustering</title><p id="Par44">Dimensionality-Reduction and clustering were performed using Seurat (version 4.0.0)<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. First the data were again normalized, scaled and the top 2000 variable genes were selected using Seurats NormalizeData, FindVariableFeatures and ScaleData functions. For the diemensionality-reduction, we used the RunPCA and the RunUMAP function with the first 10 dimensions, which was determined using Seurats ElbowPlot-Function. We performed clustering using the FindNeighbors-function with the first 10 dimensions and the FindClusters-Function with a resolution of 0.1.</p></sec><sec id="Sec17"><title>Cell type annotation</title><p id="Par45">This resulted in multiple clusters which could be assigned to B cells, T and NK cells, myeloid cells, Plasma cells and a cluster with mixed cell populations. To identify cell subclusters we next performed a second round of dimensionality-reduction and clustering of each of the previous clusters. The T/NK cell clusters are first processed independently for each batch for the filtering and then merged afterwards to perform cell type annotation. We then filtered out sub-clusters with more than 50% cells that originate only from one sample and repeated the dimensionality-reduction and clustering on the filtered data, as described for the complete set of cells. We repeated this step until no cells are filtered out. Cell sub-clusters are then checked for known marker-genes. Clusters that did not express known markers of PBMC cells or that are indicated to be low-quality or doublets are removed from the dataset, followed by another dimensionality-reduction and clustering step. The T/NK cells of the different batches are then merged, dimensionality-reduction and clustering were performed and the cells were split into CD4&#x02009;+&#x02009;, CD8+ and NK cells before continuing with the sub-clustering and the cell type annotation. After having filtered out the unwanted cells, the final sub-clusters were annotated based on known markers from literature.</p></sec><sec id="Sec18"><title>Low dimensional embedding and density computation</title><p id="Par46">An overall cell density per cell type and patient cohort was determined by first estimating the cell density per sample and cell type with the two-dimensional kernel density estimation implemented in the kde2d function of the MASS R-package (version 7.3-55). Subsequently, the density estimates were aggregated per patient cohort by averaging the obtained density estimates.</p></sec><sec id="Sec19"><title>Cell-type composition analysis</title><p id="Par47">Changes in the cell-type composition were evaluated using an unpaired Student&#x02019;s t-Test on the raw cell-type proportions and the p-values were corrected using the Benjamini-Hochberg procedure. scCODA (version 0.1.9)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> was first used with an automatically selected reference cell type and Age and AgoE as covariates. Using the selected reference cell type (CD4&#x02009;+&#x02009;T cell for the broad annotation and Treg CD4+ cell for the fine annotation), the analysis was repeated separately for males and females. The corrected Fold-changes were reported, and significant changes were determined using a p-value cut-off of 0.05.</p></sec><sec id="Sec20"><title>Differential gene expression analysis</title><p id="Par48">Differentially expressed genes on the PBMC data were determined with the pseudobulk approach implemented by the muscat<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> package (version 1.6.0). Cells were aggregated with the aggregate data function at cell type and sample level by summing up the SoupX corrected counts. The pbDS function was then used with the limma-voom<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> package to calculate the set of differentially expressed genes. The design matrix included besides the diagnosis, sample batch and sex as factors. Multiple testing adjustment was performed with the Benjamini-Hochberg procedure. Genes were subsequently filtered to be expressed in at least 5% of all cells of a cell type in at least one of the comparison patient cohorts. Genes were considered significantly de-regulated when they showed an absolute log2 fold-change above 0.5 (i.e. a log2 FC&#x02009;&#x0003c;&#x02009;-0.5 or &#x0003e; 0.5) and an adjusted p-value smaller than 0.05. Adjusted p-values were reported as given by the muscat package.</p></sec><sec id="Sec21"><title>ZEBRA Brain Atlas preparation and DEG analysis</title><p id="Par49">The study collection, pre-processing, and aggregating of the brain single-nucleus data was performed as described in Flotho et al.<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. The Blanchard et al.<sup><xref ref-type="bibr" rid="CR78">78</xref></sup> was filtered and the Hardwick et al.<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> dataset was removed due to overlaps with other studies in the dataset. The marker genes have been computed using a pseudo-bulk approach with edgeR (v3.36.0). Only cells from studies which reported a particular gene were considered for computing the DEGs. If the cells for computing the DEGs originated from more than a single study the study ID was used as a latent variable in the edgeR design matrix. For significance testing the glmQLFit method was used. Finally, the p-values have been adjusted using Benjamini-Hochberg correction of p.adjust method from the R stats package (v 4.1.3).</p></sec><sec id="Sec22"><title>ROSMAP Brain Atlas preparation and DEG analysis</title><p id="Par50">We collected and harmonized a scRNA-seq AD/CT dataset from state of the art studies using sample from the Religous Order and Aging Project (ROSMAP)<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>. In particular we used the studies syn52293433, syn18681734, syn51062116 and syn2580853.</p><p id="Par51">We utilized the Synapse client for Python (synapseclient version 4.5.1) with Python 3.11.10 to acquire all necessary metadata. For realigning the counts we use the CellRanger v8.0.1 software with the 2T2 reference genome. We removed redundancies in the data by overlapping cells and shared donors across studies and removed all duplicated cells from our downstream analysis. We apply the following QC thresholds: Genes have to be present in at least 3 cells, each cell with less than 100 unique genes has been discarded. We remove putative doublets using scrublet v0.2.2<sup><xref ref-type="bibr" rid="CR81">81</xref></sup> with default parameters, and run CellBender v0.3.2<sup><xref ref-type="bibr" rid="CR82">82</xref></sup> as well with defaults.</p><p id="Par52">We use the Allen Brain Institutes MapMyCells (RRID:SCR_024672) for cell type labeling, here only cell types with more than 100 cells have been considered for further analysis. For computing DEGs we followed the already described methodology (Methods: Differential gene expression analysis) and included all NCI and AD cases in our comparison.</p></sec><sec id="Sec23"><title>Pathway enrichment analysis</title><p id="Par53">Enriched pathways on the whole gene-set were determined by performing an unweighted gene set enrichment analysis using GeneTrail 3<sup><xref ref-type="bibr" rid="CR83">83</xref></sup> and the&#x000a0;&#x0201d;GO - Biological Process&#x0201d;,&#x000a0;&#x0201d;GO - Cellular Component&#x0201d;,&#x000a0;&#x0201d;GO - Molecular Function&#x0201d;,&#x000a0;&#x0201d;KEGG - Pathways&#x0201d;,&#x000a0;&#x0201d;Reactome - Pathways&#x0201d;,&#x000a0;&#x0201d;WikiPathways&#x0201d; and&#x000a0;&#x0201d;Pfam - Protein families&#x0201d; databases. Genes were ordered by the -log10 adjusted p-value and the absolute log2 fold-change. Only genes which were used by the models were considered. Pathway analysis for pre-selected gene subsets were performed using over-representation analysis using GeneTrail 3 with the same database<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. Pathways with an adjusted p-value smaller than 0.05 were considered significantly enriched or depleted. P-values were reported as given by GeneTrail.</p></sec><sec id="Sec24"><title>Cell-cell communication analysis</title><p id="Par54">Changes in the cell-cell communication were evaluated using the CellChat package<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> (version 1.5.0).</p></sec><sec id="Sec25"><title>Literature Search</title><p id="Par55">We performed a manually curated literature-research using PubMed-Search by combining the key-words&#x000a0;&#x0201d;Alzheimer&#x02019;s&#x0201d; and&#x000a0;&#x0201d;Parkinson&#x02019;s&#x0201d; with&#x000a0;&#x0201d;blood&#x0201d;,&#x000a0;&#x0201d;peripheral immunity&#x0201d;,&#x000a0;&#x0201d;peripheral blood&#x0201d;,&#x000a0;&#x0201d;pbmc&#x0201d; or&#x000a0;&#x0201d;&#x000a0;CSF marker&#x0201d; or&#x000a0;&#x0201d;brain&#x0201d; with and without the keyword&#x000a0;&#x0201d;sex&#x0201d; and selected papers that provide further information and previous findings on the topics of this paper. For the single-cell and bulk PBMC datasets of Alzheimer&#x02019;s and Parkinson&#x02019;s, we performed a manually curated literature-research using PubMed-Search with the terms&#x000a0;&#x0201d;transcriptomics&#x0201d;,&#x000a0;&#x0201d;single-cell&#x0201d;,&#x000a0;&#x0201d;pbmc&#x0201d;,&#x000a0;&#x0201d;human&#x0201d;,&#x000a0;&#x0201d;RNAseq&#x0201d;,&#x000a0;&#x0201d;blood&#x0201d;,&#x000a0;&#x0201d;parkinson&#x0201d;,&#x000a0;&#x0201d;alzheimer&#x0201d; and&#x000a0;&#x0201d;neurodegeneration&#x0201d; and selected all single-cell and bulk RNA-seq datasets.</p></sec><sec id="Sec26"><title>Correlation analysis</title><p id="Par56">All correlation values were determined using the Pearson&#x02019;s correlation coefficient (cor.test Function). P-values were adjusted using Benjamini-Hochberg. Correlations were considered significant if they had an adjusted p-value smaller than 0.05.</p></sec><sec id="Sec27"><title>Cosine similarity</title><p id="Par57">The similarity between changes in the gene expression was calculated as the cosine similarity between the unfiltered gene-lists ordered by their fold-changes.</p></sec><sec id="Sec28"><title>Statistics and reproducibility</title><p id="Par58">All test statistics used were conducted two-tailed, if not indicated otherwise. Computational tools requiring seed generators were set to use random but fixed initialization constants. Unless stated differently, p-values were corrected for multiple hypothesis testing using Benjamini-Hochberg. Unless stated otherwise, all analyses were performed using the baseline sample for each patient, with specifically defined analyses involving also longitudinal samples.</p></sec><sec id="Sec29"><title>Webserver implementation</title><p id="Par59">The interactive visualization website was implemented using Django v2.2.16 for the backend and bootstrap v5.0.1 for the front end. For the visualization, plotly js v2.0.0 was used for the graphs and datatables v1.10.25 for the differential expression table. The data was stored in the h5ad format and accessed with anndata v0.7.6.</p></sec><sec id="Sec30"><title>Reporting summary</title><p id="Par60">Further information on research design is available in the&#x000a0;<xref rid="MOESM11" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec31" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2025_56833_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2025_56833_MOESM2_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2025_56833_MOESM3_ESM.csv"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2025_56833_MOESM4_ESM.csv"><caption><p>Supplementary Dataset 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2025_56833_MOESM5_ESM.csv"><caption><p>Supplementary Dataset 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2025_56833_MOESM6_ESM.csv"><caption><p>Supplementary Dataset 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2025_56833_MOESM7_ESM.csv"><caption><p>Supplementary Dataset 5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41467_2025_56833_MOESM8_ESM.csv"><caption><p>Supplementary Dataset 6</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41467_2025_56833_MOESM9_ESM.csv"><caption><p>Supplementary Dataset 7</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41467_2025_56833_MOESM10_ESM.xlsx"><caption><p>Supplementary Dataset 8</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="41467_2025_56833_MOESM11_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="41467_2025_56833_MOESM12_ESM.pdf"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
</p></sec><sec id="Sec32" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM13"><media xlink:href="41467_2025_56833_MOESM13_ESM.xlsx"><caption><p>Source Data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors jointly supervised this work: Tony Wyss-Coray, Andreas Keller.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-56833-7.</p></sec><ack><title>Acknowledgements</title><p>The study has been supported by the Michael J Fox Foundation under grant agreements 14446, 17047 (subc. 125491594) and MJFF-021418. The Schaller-Nikolich-foundation provided further support for the study. Computational resources used within this study were financed through the DFG under project 466168626. The development of the software pipeline has been supported by funds of the EU (Project 101057548-EPIVINF). We thank Shao Ning Pei, I-Jane Chen, Jody Beecher, Yongwei Zhang from Complete Genomics and Zhouchun Shang from MGI-SZ for their support.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>F.G., T.F., F.K., M.F., and T.W.W. performed computational analysis. F.G., T.F., and F.K. analyzed the data and assembled the figures. J.S.G. performed the literature research. F.G., T.F., F.K., and A.K. wrote the manuscript with input from all authors. T.F. and Q.S. performed primary data processing. E.Mass and D.M.G. assisted with celltype annotation. D.M.G., O.L., D.C. provided and organized samples. P.H. developed the webserver. E.N.W. performed the CSF biomarker measurement experiments and K.I.A. supervised this part of the study. E.Meese, D.M.G. and K.P. provided field-expertise and guided clinical interpretation. C.L., Y.L., C.C., Y.Y., J.X., M.J., Z.W., T.W. performed the sequencing experiments. L.L. and Y.H. supervised the sequencing experiments. A.K. and T.W-C. designed and supervised the study.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par61"><italic>Nature Communications</italic> thanks Jennifer Yokoyama, who co-reviewed with Jake Oxendine, Sergiu Groppa and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Raw sequencing data is freely available from the sequence read archive (SRA) using accession ID SRP312418. An interactive webserver to explore the scRNA-seq count data is freely available at <ext-link ext-link-type="uri" xlink:href="https://www.ccb.uni-saarland.de/adrcsc">https://www.ccb.uni-saarland.de/adrcsc</ext-link>. As metadata, we publish sex and diagnosis to comply to Nature&#x02019;s scientific data policy.&#x000a0;<xref ref-type="sec" rid="Sec32">Source data</xref> are provided with this paper.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>The code used to analyze the data is available from GitHub<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. Source data are provided with this paper.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par62">A.K. was advisor of the company Firalis, researching RNA-based biomarkers for AD, while preparing the manuscript. C.L., Q.S., Y.L., C.C., Y.Y., J.X., M.J., Z.W., T.W., L.L., and Y.H. work for the company MGI group while working on the project. The remaining authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Scheltens</surname><given-names>P</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease</article-title><source>Lancet</source><year>2021</year><volume>397</volume><fpage>1577</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32205-4</pub-id><pub-id pub-id-type="pmid">33667416</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Scheltens, P. et al. Alzheimer&#x02019;s disease. <italic>Lancet</italic><bold>397</bold>, 1577&#x02013;1590 (2021).<pub-id pub-id-type="pmid">33667416</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Bloem</surname><given-names>BR</given-names></name><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name></person-group><article-title>Parkinson&#x02019;s disease</article-title><source>Lancet</source><year>2021</year><volume>397</volume><fpage>2284</fpage><lpage>2303</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00218-X</pub-id><pub-id pub-id-type="pmid">33848468</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bloem, B. R., Okun, M. S. &#x00026; Klein, C. Parkinson&#x02019;s disease. <italic>Lancet</italic><bold>397</bold>, 2284&#x02013;2303 (2021).<pub-id pub-id-type="pmid">33848468</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Ageing as a risk factor for neurodegenerative disease</article-title><source>Nat. Rev. Neurol.</source><year>2019</year><volume>15</volume><fpage>565</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0244-7</pub-id><pub-id pub-id-type="pmid">31501588</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. <italic>Nat. Rev. Neurol.</italic><bold>15</bold>, 565&#x02013;581 (2019).<pub-id pub-id-type="pmid">31501588</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>L</given-names></name><name><surname>Cookson</surname><given-names>MR</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>La Spada</surname><given-names>AR</given-names></name></person-group><article-title>Converging pathways in neurodegeneration, from genetics to mechanisms</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>1300</fpage><lpage>1309</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0237-7</pub-id><pub-id pub-id-type="pmid">30258237</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Gan, L., Cookson, M. R., Petrucelli, L. &#x00026; La Spada, A. R. Converging pathways in neurodegeneration, from genetics to mechanisms. <italic>Nat. Neurosci.</italic><bold>21</bold>, 1300&#x02013;1309 (2018).<pub-id pub-id-type="pmid">30258237</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Jessen</surname><given-names>F</given-names></name><etal/></person-group><article-title>The characterisation of subjective cognitive decline</article-title><source>Lancet Neurol.</source><year>2020</year><volume>19</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30368-0</pub-id><pub-id pub-id-type="pmid">31958406</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Jessen, F. et al. The characterisation of subjective cognitive decline. <italic>Lancet Neurol.</italic><bold>19</bold>, 271&#x02013;278 (2020).<pub-id pub-id-type="pmid">31958406</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mild cognitive impairment</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1262</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68542-5</pub-id><pub-id pub-id-type="pmid">16631882</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Gauthier, S. et al. Mild cognitive impairment. <italic>Lancet</italic><bold>367</bold>, 1262&#x02013;1270 (2006).<pub-id pub-id-type="pmid">16631882</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Lindestam Arlehamn</surname><given-names>CS</given-names></name><name><surname>Garretti</surname><given-names>F</given-names></name><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Sette</surname><given-names>A</given-names></name></person-group><article-title>Roles for the adaptive immune system in Parkinson&#x02019;s and Alzheimer&#x02019;s diseases</article-title><source>Curr. Opin. Immunol.</source><year>2019</year><volume>59</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2019.07.004</pub-id><pub-id pub-id-type="pmid">31430650</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Lindestam Arlehamn, C. S., Garretti, F., Sulzer, D. &#x00026; Sette, A. Roles for the adaptive immune system in Parkinson&#x02019;s and Alzheimer&#x02019;s diseases. <italic>Curr. Opin. Immunol.</italic><bold>59</bold>, 115&#x02013;120 (2019).<pub-id pub-id-type="pmid">31430650</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>RM</given-names></name></person-group><article-title>How neuroinflammation contributes to neurodegeneration</article-title><source>Science</source><year>2016</year><volume>353</volume><fpage>777</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1126/science.aag2590</pub-id><pub-id pub-id-type="pmid">27540165</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Ransohoff, R. M. How neuroinflammation contributes to neurodegeneration. <italic>Science</italic><bold>353</bold>, 777&#x02013;783 (2016).<pub-id pub-id-type="pmid">27540165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Marschallinger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain</article-title><source>Nat. Neurosci.</source><year>2020</year><volume>23</volume><fpage>194</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0566-1</pub-id><pub-id pub-id-type="pmid">31959936</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. <italic>Nat. Neurosci.</italic><bold>23</bold>, 194&#x02013;208 (2020).<pub-id pub-id-type="pmid">31959936</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Wightman</surname><given-names>DP</given-names></name><etal/></person-group><article-title>A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x02019;s disease</article-title><source>Nat. Genet</source><year>2021</year><volume>53</volume><fpage>1276</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1038/s41588-021-00921-z</pub-id><pub-id pub-id-type="pmid">34493870</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x02019;s disease. <italic>Nat. Genet</italic><bold>53</bold>, 1276&#x02013;1282 (2021).<pub-id pub-id-type="pmid">34493870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name><etal/></person-group><article-title>Single-cell transcriptomic analysis of Alzheimer&#x02019;s disease</article-title><source>Nature</source><year>2019</year><volume>570</volume><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1195-2</pub-id><pub-id pub-id-type="pmid">31042697</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer&#x02019;s disease. <italic>Nature</italic><bold>570</bold>, 332&#x02013;337 (2019).<pub-id pub-id-type="pmid">31042697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Grubman</surname><given-names>A</given-names></name><etal/></person-group><article-title>A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x02019;s disease reveals cell-type-specific gene expression regulation</article-title><source>Nat. Neurosci.</source><year>2019</year><volume>22</volume><fpage>2087</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0539-4</pub-id><pub-id pub-id-type="pmid">31768052</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Grubman, A. et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x02019;s disease reveals cell-type-specific gene expression regulation. <italic>Nat. Neurosci.</italic><bold>22</bold>, 2087&#x02013;2097 (2019).<pub-id pub-id-type="pmid">31768052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Smajic</surname><given-names>S</given-names></name><etal/></person-group><article-title>Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>964</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1093/brain/awab446</pub-id><pub-id pub-id-type="pmid">34919646</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Smajic, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. <italic>Brain</italic><bold>145</bold>, 964&#x02013;978 (2022).<pub-id pub-id-type="pmid">34919646</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><etal/></person-group><article-title>A human brain vascular atlas reveals diverse mediators of Alzheimer&#x02019;s risk</article-title><source>Nature</source><year>2022</year><volume>603</volume><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04369-3</pub-id><pub-id pub-id-type="pmid">35165441</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer&#x02019;s risk. <italic>Nature</italic><bold>603</bold>, 885&#x02013;892 (2022).<pub-id pub-id-type="pmid">35165441</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Single-cell dissection of the human brain vasculature</article-title><source>Nature</source><year>2022</year><volume>603</volume><fpage>893</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04521-7</pub-id><pub-id pub-id-type="pmid">35158371</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Garcia, F. J. et al. Single-cell dissection of the human brain vasculature. <italic>Nature</italic><bold>603</bold>, 893&#x02013;899 (2022).<pub-id pub-id-type="pmid">35158371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Hampel</surname><given-names>H</given-names></name><etal/></person-group><article-title>Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic</article-title><source>Nat. Rev. Neurol.</source><year>2018</year><volume>14</volume><fpage>639</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1038/s41582-018-0079-7</pub-id><pub-id pub-id-type="pmid">30297701</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Hampel, H. et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. <italic>Nat. Rev. Neurol.</italic><bold>14</bold>, 639&#x02013;652 (2018).<pub-id pub-id-type="pmid">30297701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gate</surname><given-names>D</given-names></name><etal/></person-group><article-title>Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer&#x02019;s disease</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1895-7</pub-id><pub-id pub-id-type="pmid">31915375</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer&#x02019;s disease. <italic>Nature</italic><bold>577</bold>, 399&#x02013;404 (2020).<pub-id pub-id-type="pmid">31915375</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Gate</surname><given-names>D</given-names></name><etal/></person-group><article-title>CD4(+) T cells contribute to neurodegeneration in Lewy body dementia</article-title><source>Science</source><year>2021</year><volume>374</volume><fpage>868</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1126/science.abf7266</pub-id><pub-id pub-id-type="pmid">34648304</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Gate, D. et al. CD4(+) T cells contribute to neurodegeneration in Lewy body dementia. <italic>Science</italic><bold>374</bold>, 868&#x02013;874 (2021).<pub-id pub-id-type="pmid">34648304</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>WA</given-names></name><name><surname>Reed</surname><given-names>MJ</given-names></name><name><surname>Logsdon</surname><given-names>AF</given-names></name><name><surname>Rhea</surname><given-names>EM</given-names></name><name><surname>Erickson</surname><given-names>MA</given-names></name></person-group><article-title>Healthy aging and the blood-brain barrier</article-title><source>Nat. Aging</source><year>2021</year><volume>1</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/s43587-021-00043-5</pub-id><pub-id pub-id-type="pmid">34368785</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Banks, W. A., Reed, M. J., Logsdon, A. F., Rhea, E. M. &#x00026; Erickson, M. A. Healthy aging and the blood-brain barrier. <italic>Nat. Aging</italic><bold>1</bold>, 243&#x02013;254 (2021).<pub-id pub-id-type="pmid">34368785</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MD</given-names></name><name><surname>Kisler</surname><given-names>K</given-names></name><name><surname>Montagne</surname><given-names>A</given-names></name><name><surname>Toga</surname><given-names>AW</given-names></name><name><surname>Zlokovic</surname><given-names>BV</given-names></name></person-group><article-title>The role of brain vasculature in neurodegenerative disorders</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>1318</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0234-x</pub-id><pub-id pub-id-type="pmid">30250261</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W. &#x00026; Zlokovic, B. V. The role of brain vasculature in neurodegenerative disorders. <italic>Nat. Neurosci.</italic><bold>21</bold>, 1318&#x02013;1331 (2018).<pub-id pub-id-type="pmid">30250261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MD</given-names></name><name><surname>Sagare</surname><given-names>AP</given-names></name><name><surname>Zlokovic</surname><given-names>BV</given-names></name></person-group><article-title>Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders</article-title><source>Nat. Rev. Neurol.</source><year>2018</year><volume>14</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2017.188</pub-id><pub-id pub-id-type="pmid">29377008</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Sweeney, M. D., Sagare, A. P. &#x00026; Zlokovic, B. V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. <italic>Nat. Rev. Neurol.</italic><bold>14</bold>, 133&#x02013;150 (2018).<pub-id pub-id-type="pmid">29377008</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Physiological blood-brain transport is impaired with age by a shift in transcytosis</article-title><source>Nature</source><year>2020</year><volume>583</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2453-z</pub-id><pub-id pub-id-type="pmid">32612231</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yang, A. C. et al. Physiological blood-brain transport is impaired with age by a shift in transcytosis. <italic>Nature</italic><bold>583</bold>, 425&#x02013;430 (2020).<pub-id pub-id-type="pmid">32612231</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer&#x02019;s disease: an observational clinical study</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2020</year><volume>91</volume><fpage>1219</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2020-323603</pub-id><pub-id pub-id-type="pmid">32968032</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Amin, J. et al. Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer&#x02019;s disease: an observational clinical study. <italic>J. Neurol. Neurosurg. Psychiatry</italic><bold>91</bold>, 1219&#x02013;1226 (2020).<pub-id pub-id-type="pmid">32968032</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name></person-group><article-title>Peripheral immune system in aging and Alzheimer&#x02019;s disease</article-title><source>Mol. Neurodegener.</source><year>2018</year><volume>13</volume><fpage>51</fpage><pub-id pub-id-type="doi">10.1186/s13024-018-0284-2</pub-id><pub-id pub-id-type="pmid">30285785</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Cao, W. &#x00026; Zheng, H. Peripheral immune system in aging and Alzheimer&#x02019;s disease. <italic>Mol. Neurodegener.</italic><bold>13</bold>, 51 (2018).<pub-id pub-id-type="pmid">30285785</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Ni Chasaide</surname><given-names>C</given-names></name><name><surname>Lynch</surname><given-names>MA</given-names></name></person-group><article-title>The role of the immune system in driving neuroinflammation</article-title><source>Brain Neurosci. Adv.</source><year>2020</year><volume>4</volume><fpage>2398212819901082</fpage><pub-id pub-id-type="doi">10.1177/2398212819901082</pub-id><pub-id pub-id-type="pmid">32219178</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Ni Chasaide, C. &#x00026; Lynch, M. A. The role of the immune system in driving neuroinflammation. <italic>Brain Neurosci. Adv.</italic><bold>4</bold>, 2398212819901082 (2020).<pub-id pub-id-type="pmid">32219178</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Priller</surname><given-names>J</given-names></name></person-group><article-title>The role of peripheral immune cells in the CNS in steady state and disease</article-title><source>Nat. Neurosci.</source><year>2017</year><volume>20</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1038/nn.4475</pub-id><pub-id pub-id-type="pmid">28092660</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Prinz, M. &#x00026; Priller, J. The role of peripheral immune cells in the CNS in steady state and disease. <italic>Nat. Neurosci.</italic><bold>20</bold>, 136&#x02013;144 (2017).<pub-id pub-id-type="pmid">28092660</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Carlisle</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease</article-title><source>NPJ Parkinsons Dis.</source><year>2021</year><volume>7</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1038/s41531-021-00180-z</pub-id><pub-id pub-id-type="pmid">33850148</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Carlisle, S. M. et al. Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease. <italic>NPJ Parkinsons Dis.</italic><bold>7</bold>, 36 (2021).<pub-id pub-id-type="pmid">33850148</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Tumpara, S. et al. Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs. <italic>Elife</italic><bold>10</bold>, 10.7554/eLife.64881 (2021).</mixed-citation></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Shigemizu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Identification of potential blood biomarkers for early diagnosis of Alzheimer&#x02019;s disease through RNA sequencing analysis</article-title><source>Alzheimers Res Ther.</source><year>2020</year><volume>12</volume><fpage>87</fpage><pub-id pub-id-type="doi">10.1186/s13195-020-00654-x</pub-id><pub-id pub-id-type="pmid">32677993</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Shigemizu, D. et al. Identification of potential blood biomarkers for early diagnosis of Alzheimer&#x02019;s disease through RNA sequencing analysis. <italic>Alzheimers Res Ther.</italic><bold>12</bold>, 87 (2020).<pub-id pub-id-type="pmid">32677993</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Schlachetzki</surname><given-names>JCM</given-names></name><etal/></person-group><article-title>A monocyte gene expression signature in the early clinical course of Parkinson&#x02019;s disease</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>10757</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-28986-7</pub-id><pub-id pub-id-type="pmid">30018301</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Schlachetzki, J. C. M. et al. A monocyte gene expression signature in the early clinical course of Parkinson&#x02019;s disease. <italic>Sci. Rep.</italic><bold>8</bold>, 10757 (2018).<pub-id pub-id-type="pmid">30018301</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantin Nissen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson&#x02019;s disease and cognition</article-title><source>Brain Behav. Immun.</source><year>2022</year><volume>101</volume><fpage>182</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2022.01.005</pub-id><pub-id pub-id-type="pmid">35026420</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Konstantin Nissen, S. et al. Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson&#x02019;s disease and cognition. <italic>Brain Behav. Immun.</italic><bold>101</bold>, 182&#x02013;193 (2022).<pub-id pub-id-type="pmid">35026420</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>F</given-names></name><etal/></person-group><article-title>Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson&#x02019;s disease progression</article-title><source>Nat. Aging</source><year>2021</year><volume>1</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/s43587-021-00042-6</pub-id><pub-id pub-id-type="pmid">37118411</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kern, F. et al. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson&#x02019;s disease progression. <italic>Nat. Aging</italic><bold>1</bold>, 309&#x02013;322 (2021).<pub-id pub-id-type="pmid">37118411</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Mila-Aloma</surname><given-names>M</given-names></name><etal/></person-group><article-title>Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer&#x02019;s disease</article-title><source>Nat. Med</source><year>2022</year><volume>28</volume><fpage>1797</fpage><lpage>1801</lpage><pub-id pub-id-type="pmid">35953717</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Mila-Aloma, M. et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer&#x02019;s disease. <italic>Nat. Med</italic><bold>28</bold>, 1797&#x02013;1801 (2022).<pub-id pub-id-type="pmid">35953717</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Schindler</surname><given-names>SE</given-names></name><name><surname>Karikari</surname><given-names>TK</given-names></name></person-group><article-title>Comorbidities confound Alzheimer&#x02019;s blood tests</article-title><source>Nat. Med</source><year>2022</year><volume>28</volume><fpage>1349</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01875-3</pub-id><pub-id pub-id-type="pmid">35788176</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Schindler, S. E. &#x00026; Karikari, T. K. Comorbidities confound Alzheimer&#x02019;s blood tests. <italic>Nat. Med</italic><bold>28</bold>, 1349&#x02013;1351 (2022).<pub-id pub-id-type="pmid">35788176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Palmqvist</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prediction of future Alzheimer&#x02019;s disease dementia using plasma phospho-tau combined with other accessible measures</article-title><source>Nat. Med</source><year>2021</year><volume>27</volume><fpage>1034</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01348-z</pub-id><pub-id pub-id-type="pmid">34031605</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Palmqvist, S. et al. Prediction of future Alzheimer&#x02019;s disease dementia using plasma phospho-tau combined with other accessible measures. <italic>Nat. Med</italic><bold>27</bold>, 1034&#x02013;1042 (2021).<pub-id pub-id-type="pmid">34031605</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>RJ</given-names></name><name><surname>Barthelemy</surname><given-names>NR</given-names></name><name><surname>Horie</surname><given-names>K</given-names></name></person-group><article-title>Another step forward in blood-based diagnostics for Alzheimer&#x02019;s disease</article-title><source>Nat. Med</source><year>2020</year><volume>26</volume><fpage>314</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0797-4</pub-id><pub-id pub-id-type="pmid">32132715</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Bateman, R. J., Barthelemy, N. R. &#x00026; Horie, K. Another step forward in blood-based diagnostics for Alzheimer&#x02019;s disease. <italic>Nat. Med</italic><bold>26</bold>, 314&#x02013;316 (2020).<pub-id pub-id-type="pmid">32132715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Schott</surname><given-names>JM</given-names></name></person-group><article-title>Biomarkers for Alzheimer&#x02019;s disease beyond amyloid and tau</article-title><source>Nat. Med</source><year>2019</year><volume>25</volume><fpage>201</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0348-z</pub-id><pub-id pub-id-type="pmid">30728536</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Zetterberg, H. &#x00026; Schott, J. M. Biomarkers for Alzheimer&#x02019;s disease beyond amyloid and tau. <italic>Nat. Med</italic><bold>25</bold>, 201&#x02013;203 (2019).<pub-id pub-id-type="pmid">30728536</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Phongpreecha, T. et al. Single-cell peripheral immunoprofiling of Alzheimer&#x02019;s and Parkinson&#x02019;s diseases. <italic>Sci. Adv.</italic><bold>6</bold>, 10.1126/sciadv.abd5575 (2020).</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Kapellos</surname><given-names>TS</given-names></name><etal/></person-group><article-title>Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases</article-title><source>Front Immunol.</source><year>2019</year><volume>10</volume><fpage>2035</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.02035</pub-id><pub-id pub-id-type="pmid">31543877</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Kapellos, T. S. et al. Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. <italic>Front Immunol.</italic><bold>10</bold>, 2035 (2019).<pub-id pub-id-type="pmid">31543877</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Gazestani</surname><given-names>V</given-names></name><etal/></person-group><article-title>Early Alzheimer&#x02019;s disease pathology in human cortex involves transient cell states</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>4438</fpage><lpage>4453 e4423</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.08.005</pub-id><pub-id pub-id-type="pmid">37774681</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Gazestani, V. et al. Early Alzheimer&#x02019;s disease pathology in human cortex involves transient cell states. <italic>Cell</italic><bold>186</bold>, 4438&#x02013;4453 e4423 (2023).<pub-id pub-id-type="pmid">37774681</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N</given-names></name><etal/></person-group><article-title>Human microglial state dynamics in Alzheimer&#x02019;s disease progression</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>4386</fpage><lpage>4403.e4329</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.08.037</pub-id><pub-id pub-id-type="pmid">37774678</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Sun, N. et al. Human microglial state dynamics in Alzheimer&#x02019;s disease progression. <italic>Cell</italic><bold>186</bold>, 4386&#x02013;4403.e4329 (2023).<pub-id pub-id-type="pmid">37774678</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name><etal/></person-group><article-title>Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer&#x02019;s disease pathology</article-title><source>Cell</source><year>2023</year><volume>186</volume><fpage>4365</fpage><lpage>4385.e4327</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.08.039</pub-id><pub-id pub-id-type="pmid">37774677</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer&#x02019;s disease pathology. <italic>Cell</italic><bold>186</bold>, 4365&#x02013;4385.e4327 (2023).<pub-id pub-id-type="pmid">37774677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Gabitto</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Integrated multimodal cell atlas of Alzheimer&#x02019;s disease</article-title><source>Res Sq.</source><year>2023</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-2921860/v1</pub-id><pub-id pub-id-type="pmid">37292694</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Gabitto, M. I. et al. Integrated multimodal cell atlas of Alzheimer&#x02019;s disease. <italic>Res Sq.</italic>10.21203/rs.3.rs-2921860/v1 (2023).<pub-id pub-id-type="pmid">37292694</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N</given-names></name><etal/></person-group><article-title>Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer&#x02019;s disease</article-title><source>Nat. Neurosci.</source><year>2023</year><volume>26</volume><fpage>970</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1038/s41593-023-01334-3</pub-id><pub-id pub-id-type="pmid">37264161</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Sun, N. et al. Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer&#x02019;s disease. <italic>Nat. Neurosci.</italic><bold>26</bold>, 970&#x02013;982 (2023).<pub-id pub-id-type="pmid">37264161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Dysregulation of brain and choroid plexus cell types in severe COVID-19</article-title><source>Nature</source><year>2021</year><volume>595</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03710-0</pub-id><pub-id pub-id-type="pmid">34153974</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Yang, A. C. et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. <italic>Nature</italic><bold>595</bold>, 565&#x02013;571 (2021).<pub-id pub-id-type="pmid">34153974</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>X</given-names></name><etal/></person-group><article-title>COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>1895</fpage><lpage>1913.e1819</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.053</pub-id><pub-id pub-id-type="pmid">33657410</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. <italic>Cell</italic><bold>184</bold>, 1895&#x02013;1913.e1819 (2021).<pub-id pub-id-type="pmid">33657410</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Single-cell multi-omics analysis of the immune response in COVID-19</article-title><source>Nat. Med</source><year>2021</year><volume>27</volume><fpage>904</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01329-2</pub-id><pub-id pub-id-type="pmid">33879890</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. <italic>Nat. Med</italic><bold>27</bold>, 904&#x02013;916 (2021).<pub-id pub-id-type="pmid">33879890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cell subtype-specific effects of genetic variation in the Alzheimer&#x02019;s disease brain</article-title><source>Nat. Genet</source><year>2024</year><volume>56</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/s41588-024-01685-y</pub-id><pub-id pub-id-type="pmid">38514782</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Fujita, M. et al. Cell subtype-specific effects of genetic variation in the Alzheimer&#x02019;s disease brain. <italic>Nat. Genet</italic><bold>56</bold>, 605&#x02013;614 (2024).<pub-id pub-id-type="pmid">38514782</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>A portable and cost-effective microfluidic system for massively parallel single-cell transcriptome profiling</article-title><source>biorxiv</source><year>2019</year><pub-id pub-id-type="doi">10.1101/818450</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Liu, C. et al. A portable and cost-effective microfluidic system for massively parallel single-cell transcriptome profiling. <italic>biorxiv</italic>10.1101/818450 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Huang, Z. et al. Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. <italic>Proc. Natl Acad. Sci. USA</italic><bold>118</bold>, 10.1073/pnas.2023216118 (2021).</mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Flotho</surname><given-names>M</given-names></name><etal/></person-group><article-title>ZEBRA: a hierarchically integrated gene expression atlas of the murine and human brain at single-cell resolution</article-title><source>Nucleic Acids Res</source><year>2024</year><volume>52</volume><fpage>D1089</fpage><lpage>D1096</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad990</pub-id><pub-id pub-id-type="pmid">37941147</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Flotho, M. et al. ZEBRA: a hierarchically integrated gene expression atlas of the murine and human brain at single-cell resolution. <italic>Nucleic Acids Res</italic><bold>52</bold>, D1089&#x02013;D1096 (2024).<pub-id pub-id-type="pmid">37941147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Lovheim</surname><given-names>H</given-names></name><etal/></person-group><article-title>Herpes simplex infection and the risk of Alzheimer&#x02019;s disease: A nested case-control study</article-title><source>Alzheimers Dement</source><year>2015</year><volume>11</volume><fpage>587</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2014.07.157</pub-id><pub-id pub-id-type="pmid">25304990</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Lovheim, H. et al. Herpes simplex infection and the risk of Alzheimer&#x02019;s disease: A nested case-control study. <italic>Alzheimers Dement</italic><bold>11</bold>, 587&#x02013;592 (2015).<pub-id pub-id-type="pmid">25304990</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Linard</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2020</year><volume>16</volume><fpage>200</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1002/alz.12008</pub-id><pub-id pub-id-type="pmid">31914220</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Linard, M. et al. Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer&#x02019;s disease. <italic>Alzheimers Dement</italic><bold>16</bold>, 200&#x02013;208 (2020).<pub-id pub-id-type="pmid">31914220</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><article-title>CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics</article-title><source>Nat. Protoc.</source><year>2024</year><pub-id pub-id-type="doi">10.1038/s41596-024-01045-4</pub-id><pub-id pub-id-type="pmid">39289563</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Jin, S., Plikus, M. V. &#x00026; Nie, Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. <italic>Nat. Protoc.</italic>10.1038/s41596-024-01045-4 (2024).<pub-id pub-id-type="pmid">39289563</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HC</given-names></name><name><surname>Zong</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>WY</given-names></name><name><surname>Han</surname><given-names>YS</given-names></name></person-group><article-title>Chemokines in patients with Alzheimer&#x02019;s disease: A meta-analysis</article-title><source>Front Aging Neurosci.</source><year>2023</year><volume>15</volume><fpage>ARTN 1047810</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2023.1047810</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Wang, H. C., Zong, Y., Zhu, L., Wang, W. Y. &#x00026; Han, Y. S. Chemokines in patients with Alzheimer&#x02019;s disease: A meta-analysis. <italic>Front Aging Neurosci.</italic><bold>15</bold>, ARTN 1047810 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Neuronal MHC-I complex is destabilized by amyloid-beta and its implications in Alzheimer&#x02019;s disease</article-title><source>Cell Biosci.</source><year>2023</year><volume>13</volume><fpage>181</fpage><pub-id pub-id-type="doi">10.1186/s13578-023-01132-1</pub-id><pub-id pub-id-type="pmid">37773139</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Kim, M. S. et al. Neuronal MHC-I complex is destabilized by amyloid-beta and its implications in Alzheimer&#x02019;s disease. <italic>Cell Biosci.</italic><bold>13</bold>, 181 (2023).<pub-id pub-id-type="pmid">37773139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer&#x02019;s disease mice</article-title><source>J. Neurosci.</source><year>2011</year><volume>31</volume><fpage>1355</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3268-10.2011</pub-id><pub-id pub-id-type="pmid">21273420</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Zhu, Y. et al. CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer&#x02019;s disease mice. <italic>J. Neurosci.</italic><bold>31</bold>, 1355&#x02013;1365 (2011).<pub-id pub-id-type="pmid">21273420</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer&#x02019;s disease</article-title><source>Exp. Mol. Med</source><year>2021</year><volume>53</volume><fpage>1888</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1038/s12276-021-00714-8</pub-id><pub-id pub-id-type="pmid">34880454</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Xiong, L. L. et al. Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer&#x02019;s disease. <italic>Exp. Mol. Med</italic><bold>53</bold>, 1888&#x02013;1901 (2021).<pub-id pub-id-type="pmid">34880454</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Shad</surname><given-names>KF</given-names></name><name><surname>Aghazadeh</surname><given-names>Y</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Kress</surname><given-names>B</given-names></name></person-group><article-title>Peripheral markers of Alzheimer&#x02019;s disease: surveillance of white blood cells</article-title><source>Synapse</source><year>2013</year><volume>67</volume><fpage>541</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1002/syn.21651</pub-id><pub-id pub-id-type="pmid">23404438</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Shad, K. F., Aghazadeh, Y., Ahmad, S. &#x00026; Kress, B. Peripheral markers of Alzheimer&#x02019;s disease: surveillance of white blood cells. <italic>Synapse</italic><bold>67</bold>, 541&#x02013;543 (2013).<pub-id pub-id-type="pmid">23404438</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Kashima, Y. et al. Intensive single-cell analysis reveals immune-cell diversity among healthy individuals. <italic>Life Sci Alliance</italic><bold>5</bold>, 10.26508/lsa.202201398 (2022).</mixed-citation></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanwani</surname><given-names>R</given-names></name><etal/></person-group><article-title>Transcriptional analysis of peripheral memory T cells reveals Parkinson&#x02019;s disease-specific gene signatures</article-title><source>NPJ Parkinsons Dis.</source><year>2022</year><volume>8</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1038/s41531-022-00282-2</pub-id><pub-id pub-id-type="pmid">35314697</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Dhanwani, R. et al. Transcriptional analysis of peripheral memory T cells reveals Parkinson&#x02019;s disease-specific gene signatures. <italic>NPJ Parkinsons Dis.</italic><bold>8</bold>, 30 (2022).<pub-id pub-id-type="pmid">35314697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Tranchevent</surname><given-names>LC</given-names></name><name><surname>Halder</surname><given-names>R</given-names></name><name><surname>Glaab</surname><given-names>E</given-names></name></person-group><article-title>Systems level analysis of sex-dependent gene expression changes in Parkinson&#x02019;s disease</article-title><source>NPJ Parkinsons Dis.</source><year>2023</year><volume>9</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s41531-023-00446-8</pub-id><pub-id pub-id-type="pmid">36681675</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Tranchevent, L. C., Halder, R. &#x00026; Glaab, E. Systems level analysis of sex-dependent gene expression changes in Parkinson&#x02019;s disease. <italic>NPJ Parkinsons Dis.</italic><bold>9</bold>, 8 (2023).<pub-id pub-id-type="pmid">36681675</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">Patel, S. et al. Donor-Specific Transcriptomic Analysis of Alzheimer&#x02019;s Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia. <italic>eNeuro</italic><bold>7</bold>, 10.1523/ENEURO.0255-20.2020 (2020).</mixed-citation></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Flinkman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson&#x02019;s disease</article-title><source>NPJ Parkinsons Dis.</source><year>2023</year><volume>9</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1038/s41531-023-00460-w</pub-id><pub-id pub-id-type="pmid">36746972</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Flinkman, D. et al. Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson&#x02019;s disease. <italic>NPJ Parkinsons Dis.</italic><bold>9</bold>, 20 (2023).<pub-id pub-id-type="pmid">36746972</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Hernandez, S. M. et al. Unexpected Implication of SRP and AGO2 in Parkinson&#x02019;s Disease: Involvement in Alpha-Synuclein Biogenesis. <italic>Cells</italic><bold>10</bold>, 10.3390/cells10102792 (2021).</mixed-citation></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Felsky</surname><given-names>D</given-names></name><etal/></person-group><article-title>The Caribbean-Hispanic Alzheimer&#x02019;s disease brain transcriptome reveals ancestry-specific disease mechanisms</article-title><source>Neurobiol. Dis.</source><year>2023</year><volume>176</volume><fpage>105938</fpage><pub-id pub-id-type="doi">10.1016/j.nbd.2022.105938</pub-id><pub-id pub-id-type="pmid">36462719</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Felsky, D. et al. The Caribbean-Hispanic Alzheimer&#x02019;s disease brain transcriptome reveals ancestry-specific disease mechanisms. <italic>Neurobiol. Dis.</italic><bold>176</bold>, 105938 (2023).<pub-id pub-id-type="pmid">36462719</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Ilievski</surname><given-names>V</given-names></name><etal/></person-group><article-title>Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><fpage>e0204941</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0204941</pub-id><pub-id pub-id-type="pmid">30281647</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Ilievski, V. et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. <italic>PLoS One</italic><bold>13</bold>, e0204941 (2018).<pub-id pub-id-type="pmid">30281647</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Dominy</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Porphyromonas gingivalis in Alzheimer&#x02019;s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>eaau3333</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aau3333</pub-id><pub-id pub-id-type="pmid">30746447</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Dominy, S. S. et al. Porphyromonas gingivalis in Alzheimer&#x02019;s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. <italic>Sci. Adv.</italic><bold>5</bold>, eaau3333 (2019).<pub-id pub-id-type="pmid">30746447</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><etal/></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. <italic>Bioinformatics</italic><bold>29</bold>, 15&#x02013;21 (2013).<pub-id pub-id-type="pmid">23104886</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Tarasov</surname><given-names>A</given-names></name><name><surname>Vilella</surname><given-names>AJ</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name><name><surname>Nijman</surname><given-names>IJ</given-names></name><name><surname>Prins</surname><given-names>P</given-names></name></person-group><article-title>Sambamba: fast processing of NGS alignment formats</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>2032</fpage><lpage>2034</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv098</pub-id><pub-id pub-id-type="pmid">25697820</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. &#x00026; Prins, P. Sambamba: fast processing of NGS alignment formats. <italic>Bioinformatics</italic><bold>31</bold>, 2032&#x02013;2034 (2015).<pub-id pub-id-type="pmid">25697820</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Frankish</surname><given-names>A</given-names></name><etal/></person-group><article-title>Gencode 2021</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>D916</fpage><lpage>D923</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1087</pub-id><pub-id pub-id-type="pmid">33270111</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Frankish, A. et al. Gencode 2021. <italic>Nucleic Acids Res</italic><bold>49</bold>, D916&#x02013;D923 (2021).<pub-id pub-id-type="pmid">33270111</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Young, M. D. &#x00026; Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. <italic>Gigascience</italic><bold>9</bold>, 10.1093/gigascience/giaa151 (2020).</mixed-citation></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>PL</given-names></name><name><surname>Lun</surname><given-names>A</given-names></name><name><surname>Garcia Meixide</surname><given-names>C</given-names></name><name><surname>Macnair</surname><given-names>W</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><article-title>Doublet identification in single-cell sequencing data using scDblFinder</article-title><source>F1000Res</source><year>2021</year><volume>10</volume><fpage>979</fpage><pub-id pub-id-type="doi">10.12688/f1000research.73600.1</pub-id><pub-id pub-id-type="pmid">35814628</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Germain, P. L., Lun, A., Garcia Meixide, C., Macnair, W. &#x00026; Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. <italic>F1000Res</italic><bold>10</bold>, 979 (2021).<pub-id pub-id-type="pmid">35814628</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dictionary learning for integrative, multimodal and scalable single-cell analysis</article-title><source>Nat. Biotechnol.</source><year>2024</year><volume>42</volume><fpage>293</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41587-023-01767-y</pub-id><pub-id pub-id-type="pmid">37231261</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. <italic>Nat. Biotechnol.</italic><bold>42</bold>, 293&#x02013;304 (2024).<pub-id pub-id-type="pmid">37231261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Buttner</surname><given-names>M</given-names></name><name><surname>Ostner</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>CL</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Schubert</surname><given-names>B</given-names></name></person-group><article-title>scCODA is a Bayesian model for compositional single-cell data analysis</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>6876</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-27150-6</pub-id><pub-id pub-id-type="pmid">34824236</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Buttner, M., Ostner, J., Muller, C. L., Theis, F. J. &#x00026; Schubert, B. scCODA is a Bayesian model for compositional single-cell data analysis. <italic>Nat. Commun.</italic><bold>12</bold>, 6876 (2021).<pub-id pub-id-type="pmid">34824236</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Crowell</surname><given-names>HL</given-names></name><etal/></person-group><article-title>muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>6077</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19894-4</pub-id><pub-id pub-id-type="pmid">33257685</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Crowell, H. L. et al. muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. <italic>Nat. Commun.</italic><bold>11</bold>, 6077 (2020).<pub-id pub-id-type="pmid">33257685</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><fpage>R29</fpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id><pub-id pub-id-type="pmid">24485249</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Law, C. W., Chen, Y., Shi, W. &#x00026; Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. <italic>Genome Biol.</italic><bold>15</bold>, R29 (2014).<pub-id pub-id-type="pmid">24485249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>JW</given-names></name><etal/></person-group><article-title>APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes</article-title><source>Nature</source><year>2022</year><volume>611</volume><fpage>769</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05439-w</pub-id><pub-id pub-id-type="pmid">36385529</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Blanchard, J. W. et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. <italic>Nature</italic><bold>611</bold>, 769&#x02013;779 (2022).<pub-id pub-id-type="pmid">36385529</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Hardwick</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue</article-title><source>Nat. Biotechnol.</source><year>2022</year><volume>40</volume><fpage>1082</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01231-3</pub-id><pub-id pub-id-type="pmid">35256815</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Hardwick, S. A. et al. Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue. <italic>Nat. Biotechnol.</italic><bold>40</bold>, 1082&#x02013;1092 (2022).<pub-id pub-id-type="pmid">35256815</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">P&#x000e9;rez-Gonz&#x000e1;lez, A. P. et al. The ROSMAP project: aging and neurodegenerative diseases through omic sciences. <italic>Front Neuroinform</italic>. <bold>18</bold>, 1443865 (2024).</mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">Samuel L. Wolock, Romain Lopez, &#x00026; Allon M. Klein. Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. <italic>Cell Syst</italic>. <bold>8</bold>, 281&#x02013;291.e9 (2019).</mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. <italic>Nat Methods</italic><bold>20</bold>, 1323&#x02013;1335 (2023).</mixed-citation></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Gerstner</surname><given-names>N</given-names></name><etal/></person-group><article-title>GeneTrail 3: advanced high-throughput enrichment analysis</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>W515</fpage><lpage>W520</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa306</pub-id><pub-id pub-id-type="pmid">32379325</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Gerstner, N. et al. GeneTrail 3: advanced high-throughput enrichment analysis. <italic>Nucleic Acids Res</italic><bold>48</bold>, W515&#x02013;W520 (2020).<pub-id pub-id-type="pmid">32379325</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Grandke</surname><given-names>F</given-names></name><name><surname>Fehlmann</surname><given-names>T</given-names></name><name><surname>Flotho</surname><given-names>M</given-names></name><name><surname>Wolff</surname><given-names>TW</given-names></name></person-group><article-title>A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration</article-title><source>Github: adrcsc</source><year>2025</year><pub-id pub-id-type="doi">10.5281/zenodo.14641642</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Grandke, F., Fehlmann, T., Flotho, M. &#x00026; Wolff, T. W. A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration. <italic>Github: adrcsc</italic>10.5281/zenodo.14641642 (2025).</mixed-citation></citation-alternatives></ref></ref-list></back></article>